| Title | Bone marrow edema syndrome in postpartal women: treatment with iloprost. | | Author(s) | Aigner N, Meizer R, Meraner D, Becker S, Meizer E, Landsiedl F | | Institution | Orthopedic Hospital Vienna Speising, Speisingerstrasse 109, Vienna 1130, Austria. nicolas.aigner@oss.at | | Source | Orthop Clin North Am 2009 Apr; 40(2):241-7. | | MeSH | Adult
Arthralgia
Bone Marrow Diseases
Diagnosis, Differential
Dose-Response Relationship, Drug
Edema
Female
Femur Head
Follow-Up Studies
Hip Joint
Humans
Iloprost
Injections, Intravenous
Magnetic Resonance Imaging
Pilot Projects
Postpartum Period
Pregnancy
Pregnancy Complications
Prospective Studies
Recovery of Function
Syndrome
Treatment Outcome
Vasodilator Agents
| | Abstract | Bone marrow edema syndrome of the femoral head in pregnant women is a rare disease resulting in disabling coxalgia, beginning in the last 3 months of pregnancy and persisting for several months after parturition. The parenteral administration of the vasoactive drug iloprost constitutes a new approach to the treatment of painful bone marrow edema syndrome of the hip of pregnant women. Six postpartal women (8 hips) with bone marrow edema syndrome of the femoral head were treated with iloprost followed by 3 weeks of partial weight-bearing. Relief from pain, restoration of functional capacity, and normalization of the MRI signal pattern were rapidly achieved, thus avoiding the need for surgical intervention. As the substance is contraindicated in pregnancy, therapy may begin only some days after parturition, with a short discontinuation in breastfeeding. | | Language | eng | | Pub Type(s) | Comparative Study
Journal Article
| | PubMed ID | 19358909 |
|
